Skip Navigation LinksHome > January 2014 - Volume 21 - Issue 1 > SATB2 is a Novel Marker of Osteoblastic Differentiation and...
Advances in Anatomic Pathology:
doi: 10.1097/PAP.0000000000000001
New Antibody/Techniques

SATB2 is a Novel Marker of Osteoblastic Differentiation and Colorectal Adenocarcinoma

Ordóñez, Nelson G. MD

Collapse Box

Abstract

SATB2 is a nuclear matrix-associated transcription factor and epigenetic regulator that is involved in osteoblastic differentiation and is also expressed in the glandular epithelial cells of the lower gastrointestinal tract. Recent studies have shown that, because of its relative specificity for osteoblastic differentiation, SATB2 immunostaining could potentially be a useful adjunct for assisting in the differential diagnosis of both benign and malignant osteogenic tumors. In addition, because SATB2 is also a highly sensitive and specific marker for colorectal adenocarcinomas, it could also serve as a complementary marker in the differential diagnosis of a carcinoma of unknown primary origin.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.